(NASDAQ: MBIO) Mustang Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.33%.
Mustang Bio's earnings in 2024 is -$32,064,000.On average, 1 Wall Street analyst forecast MBIO's earnings for 2024 to be -$22,711,899, with the lowest MBIO earnings forecast at -$22,711,899, and the highest MBIO earnings forecast at -$22,711,899.
In 2025, MBIO is forecast to generate -$13,031,417 in earnings, with the lowest earnings forecast at -$13,031,417 and the highest earnings forecast at -$13,031,417.